Showing results (821-830 of 885) with videos related to
Sort By:
Pageof 89
Journal of Medical Internet Research|January 7, 2017
IntelliCare: An Eclectic, Skills-Based App Suite for the Treatment of Depression and AnxietyDavid C Mohr, Kathryn Noth Tomasino, Emily G Lattie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord OvestAlfredo Falcone, Sergio Ricci, Isa Brunetti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trialsC Cremolini, F Loupakis, G Masi, et al.Oncotarget|December 20, 2017
Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteinsTujin Shi, Sue-Ing Quek, Yuqian Gao, et al.Ecancermedicalscience|June 23, 2020
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical OncologistsLivio Blasi, Roberto Bordonaro, Nicolò Borsellino, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2015
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord OvestC Cremolini, F Loupakis, C Antoniotti, et al.Plos One|February 14, 2025
Disease trajectory and competing risks of patients with cirrhosis in the USMohsen Mohammadi, Bima J Hasjim, Salva N Balbale, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2023
Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD studyFabio Salvatore Macaluso, Elvira D'Antonio, Walter Fries, et al.Oncotarget|June 9, 2016
Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammationDaniel R Principe, Brian DeCant, Jonas Staudacher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic CancerKrishay Sridalla, Jasmine K Machhi, Dominic J Vitello, et al.Pageof 89